China Adds 199 Innovative Drugs to Medical Insurance List ๐
China expands medical coverage with 199 new drugs, benefiting 1.17B patients and reshaping healthcare accessibility in 2026.
๐NewspaperAmigo โ Your Global News Buddy ๐๏ธ
Timely Reports, Friendly Voices โ Your Daily News Amigo
China expands medical coverage with 199 new drugs, benefiting 1.17B patients and reshaping healthcare accessibility in 2026.
Global pharmaceutical giants like Eli Lilly and AstraZeneca are pouring billions into China’s biotech sector, driven by new policies and market potential. ๐๐ก
In China, ‘hospital companions’ emerge as vital allies for elderly and vulnerable patients navigating tech-driven healthcare systems. ๐ค๐ฅ #HealthTech
On Rare Disease Day 2026, discover how tech, policy, and global collaboration are transforming care for 420 million patients worldwide. ๐๐ฉบ
China’s top thoracic surgeon Zhou Qinghua debates balancing medical innovation with patient-centered care in 2026’s lung cancer treatment landscape.
Surgeons used a groundbreaking artificial lung system to keep a patient alive for two days without lungs, enabling a life-saving transplant. ๐ฉบ #MedicalMiracle
AstraZeneca announces a $15 billion investment in China during UK PM Starmer’s visit, signaling strong confidence in the country’s healthcare innovation.
China’s first national disease classification system for Tibetan medicine, launched in 2025, is revolutionizing traditional healthcare with 3,000+ coded conditions. ๐๐
Despite losing his voice, Cai Lei’s AI-driven advocacy has fueled 200+ ALS treatment pipelines in China, inspiring global research. ๐ง ๐ก
U.S. and Chinese hospitals deepen critical care collaboration through exchanges and research, bridging medical expertise for global health. ๐๐ฅ